Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience.
Ann Rheum Dis
; 81(10): e188, 2022 10.
Article
em En
| MEDLINE
| ID: mdl-32732244
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Médicos
/
Reumatologia
/
Doenças Reumáticas
/
Tratamento Farmacológico da COVID-19
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article